Skip to main content
Clinical Trials/NCT05748535
NCT05748535
Completed
Not Applicable

The Effect of Auricular Vagus Nerve Stimulation on Pain and Pulse Variability in Women With Migraine Disease

Bahçeşehir University1 site in 1 country60 target enrollmentJune 6, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Migraine, Headache
Sponsor
Bahçeşehir University
Enrollment
60
Locations
1
Primary Endpoint
Numerical Pain Rating Scale
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of the study was to investigate the effectiveness of non-invasive auricular vagus nerve stimulation on pain and pulse variability in women aged 18-55 years with migraine. It is also aimed to see the effects of vagus nerve stimulation from all directions by making pain, pulse, blood pressure and autonomic measurements.

Detailed Description

Migraine, a neurological disorder that causes severe disability, is characterized by recurrent moderate to severe attacks associated with vegetative symptoms. Patients with frequent attacks may overuse drugs, which can lead to migraine chronization and headache. In the last decade, neuromodulatory approaches have been developed for the treatment of headaches that do not respond adequately to treatment. Non-invasive neuromodulation techniques are an evolving field in migraine research and treatment. Non-invasive vagus nerve stimulation is one of the non-invasive neuromodulation techniques. Promising findings on vagus nerve stimulation in people with chronic pain, including migraine and cluster headaches, are slowly being recognized. Stimulation of the vagus nerve provides a way of regulating autonomic tone. Auricular vagus nerve stimulation regulates abnormal sympatho-vagal balance while activating the parasympathetic system, including anti-inflammatory pathways (cholinergic anti-inflammatory pathway and hypothalamic-pituitary adrenal axis). It is aimed to evaluate the effect on pain and pulse variability after vagus nerve stimulation in women with migraine disease and to learn how the vagus nerve crosses according to the pulse measurements taken from the right and left index fingers.

Registry
clinicaltrials.gov
Start Date
June 6, 2022
End Date
January 27, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Bahçeşehir University
Responsible Party
Principal Investigator
Principal Investigator

Sule Okur

Lecturer, Physiotherapist

Bahçeşehir University

Eligibility Criteria

Inclusion Criteria

  • People between the ages of 18-55 with migraine disease
  • Having a definite diagnosis of migraine by a neurologist
  • Absence of any orthopedic, neurological, etc. diseases that will prevent physical activity
  • Not using drugs continuously except for migraine attacks
  • Willingness to participate in the study
  • Having signed the informed consent form

Exclusion Criteria

  • Cases do not want to continue the study.
  • Not signing the informed consent form
  • Being on medication for migraine prophylaxis
  • Having a communication problem that does not allow evaluation
  • Having a history of additional chronic disease that interferes with physical activity,
  • Pregnancy

Outcomes

Primary Outcomes

Numerical Pain Rating Scale

Time Frame: 1 month

The Numerical Pain Rating Scale is a widely used scale that requires the patient to rate their pain on a scale of 0 to 10; 0 indicates no pain and 10 reflects the worst possible pain.

Headache Impact Test (HIT-6)

Time Frame: 1 month

It is a short questionnaire designed to evaluate migraine pain from the patient's perspective and to track the time lost by the patient due to migraine (work, school, housework, social activities).

Pulse Variability/ Elite HRV Cor Sense Monitor

Time Frame: 1 month

CorSense HRV monitors are used in this study Elite HRV purchased from the company. Readings will be collected through the Elite HRV app designed for mobile devices. The platform is R-R registered via industry standard, according to the Elite HRV website. ranges and defines 0.04-0.15 Hz waves as LF and 0.15-0.40 Hz waves as HF.

Blood Pressure

Time Frame: 1 month

Blood pressure is the pressure that the heart creates on the vessel wall as it pumps blood through our body.

Study Sites (1)

Loading locations...

Similar Trials